Clinical trial
Effect of Farxiga on Renal Function and Size in Type 2 Diabetic Patients With Hyperfiltration
NCT02911792 is registered in ClinicalTrials.gov with The University of Texas Health Science Center at San Antonio as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Effect of Farxiga on Renal Function and Size in Type 2 Diabetic Patients With Hyperfiltration
- Lead sponsor
- The University of Texas Health Science Center at San Antonio
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- December 20, 2016
- Completion date
- July 11, 2023
- Enrollment
- 72 (actual)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.